To view Track names, descriptions, objectives and target audience, click here.

Sessions scheduled on Wednesday, April 27 at 1:15, 2:30 and 3:45 are for RCM CLIENTS ONLY

SCM and other clients are not eligible to attend these sessions and will be participating in the Vendor Fair at this time.

*Accreditations appearing on this website are pending approval by the appropriate crediting agencies. Although MedAssets does not anticipate any denials, pleae check the signage outside the session room for final approvals.

CSL Behring

King of Prussia,  PA 
United States
  • Booth: 736

CSL Behring is a leading global biotherapeutics company with a broad range of innovative plasma-derived and recombinant therapies. For over a century, we have been driven by our promise to save lives. Today, our therapies include those to treat coagulation disorders, primary immune deficiencies, and hereditary angioedema among others.